The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
A review on anticancer potential of bioactive heterocycle quinoline
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
The Bcl-2 family: roles in cell survival and oncogenesis
Cory, S., Huang, D. C. S., & Adams, J. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207102 · Cited by 1,463
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
LITCHFIELD, D. W. (2003) · Biochemical Journal · doi:10.1042/bj20021469 · Cited by 1,233
Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA
Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J., & Hol, W. G. J. (1998) · Science · doi:10.1126/science.279.5356.1504 · Cited by 889
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Hsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
Development of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Matsui, J., Funahashi, Y., Uenaka, T., Watanabe, T., Tsuruoka, A., & Asada, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5270 · Cited by 530
Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 509
Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., Bliesath, J., Omori, M., Huser, N., Ho, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1893 · Cited by 506
Calabrese, C. R., Almassy, R., Barton, S., Batey, M. A., Calvert, A. H., Canan-Koch, S., Durkacz, B. W., Hostomsky, Z., Kumpf, R. A., Kyle, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh005 · Cited by 487
RET tyrosine kinase signaling in development and cancer
Arighi, E., Borrello, M. G., & Sariola, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.010 · Cited by 468
Cortes, J. E., Kim, D.-W., Kantarjian, H. M., Brümmendorf, T. H., Dyagil, I., Griskevicius, L., Malhotra, H., Powell, C., Gogat, K., Countouriotis, A. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.7522 · Cited by 466
Cortes, J. E., Kantarjian, H. M., Brümmendorf, T. H., Kim, D.-W., Turkina, A. G., Shen, Z.-X., Pasquini, R., Khoury, H. J., Arkin, S., Volkert, A., et al. (2011) · Blood · doi:10.1182/blood-2011-05-355594 · Cited by 463
(1992) · PubMed · Cited by 383
Plant-based anticancer molecules: A chemical and biological profile of some important leads
Srivastava, V., Negi, A., Kumar, J. K., Gupta, M. M., & Khanuja, S. P. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.066 · Cited by 379
Puttini, M., Coluccia, A. M. L., Boschelli, F., Cleris, L., Marchesi, E., Donella-Deana, A., Ahmed, S., Redaelli, S., Piazza, R., Magistroni, V., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1199 · Cited by 375
Expression of Neurturin, GDNF, and GDNF Family-Receptor mRNA in the Developing and Mature Mouse
Golden, J. P., DeMaro, J. A., Osborne, P. A., Milbrandt, J., & Johnson, E. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7127 · Cited by 360
Adsule, S., Barve, V., Chen, D., Ahmed, F., Dou, Q. P., Padhye, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060712l · Cited by 334
Tsou, H.-R., Overbeek-Klumpers, E. G., Hallett, W. A., Reich, M. F., Floyd, M. B., Johnson, B. D., Michalak, R. S., Nilakantan, R., Discafani, C., Golas, J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040159c · Cited by 301
Camptothecins: A Review of Their Chemotherapeutic Potential
Ulukan, H., & Swaan, P. W. (2002) · Drugs · doi:10.2165/00003495-200262140-00004 · Cited by 299
Pierre, F., Chua, P. C., O’Brien, S. E., Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J., Schwaebe, M. K., Stefan, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101251q · Cited by 296
Protein tyrosine kinases and cancer
Kolibaba, K. S., & Druker, B. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00022-x · Cited by 291
Protein kinase CK2 in mammary gland tumorigenesis
Landesman-Bollag, E., Romieu-Mourez, R., Song, D. H., Sonenshein, G. E., Cardiff, R. D., & Seldin, D. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204411 · Cited by 289
Wissner, A., Overbeek, E., Reich, M. F., Floyd, M. B., Johnson, B. D., Mamuya, N., Rosfjord, E. C., Discafani, C., Davis, R., Shi, X., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020241c · Cited by 264
Liu, Q., Chang, J. W., Wang, J., Kang, S. A., Thoreen, C. C., Markhard, A., Hur, W., Zhang, J., Sim, T., Sabatini, D. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101144f · Cited by 257
Anticancer Activity of the Antibiotic Clioquinol
Ding, W.-Q., Liu, B., Vaught, J. L., Yamauchi, H., & Lind, S. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3577 · Cited by 248
Protein Kinase CK2 in Human Diseases
Guerra, B., & Issinger, O.-G. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132933 · Cited by 242
Liu, Q., Wang, J., Kang, S. A., Thoreen, C. C., Hur, W., Ahmed, T., Sabatini, D. M., & Gray, N. S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101520v · Cited by 219
Wissner, A., Berger, D. M., Boschelli, D. H., Floyd, M. B., Greenberger, L. M., Gruber, B. C., Johnson, B. D., Mamuya, N., Nilakantan, R., Reich, M. F., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000206a · Cited by 207
Lazo, J. S., Aslan, D. C., Southwick, E. C., Cooley, K. A., Ducruet, A. P., Joo, B., Vogt, A., & Wipf, P. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102046 · Cited by 190
Zhou, J.-L., Lu, Y.-J., Ou, T.-M., Zhou, J.-M., Huang, Z.-S., Zhu, X.-F., Du, C.-J., Bu, X.-Z., Ma, L., Gu, L.-Q., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050041b · Cited by 175
Magedov, I. V., Manpadi, M., Ogasawara, M. A., Dhawan, A. S., Rogelj, S., Van slambrouck, S., Steelant, W. F. A., Evdokimov, N. M., Uglinskii, P. Y., Elias, E. M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701499n · Cited by 173
Vultur, A., Buettner, R., Kowolik, C., Liang, W., Smith, D., Boschelli, F., & Jove, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0126 · Cited by 170
Bellusci, S., Moens, G., Gaudino, G., Comoglio, P. M., Nakamura, T., Thiery, J. P., & Jouanneau, J. (1994) · PubMed · Cited by 168
Scott Sawyer, J., Beight, D. W., Britt, K. S., Anderson, B. D., Campbell, R. M., Goodson, T., Herron, D. K., Li, H.-Y., McMillen, W. T., Mort, N., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.007 · Cited by 166
Katsarou, M. E., Efthimiadou, E. K., Psomas, G., Karaliota, A., & Vourloumis, D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7013259 · Cited by 162
Asymmetric Expression of Protein Kinase CK2 Subunits in Human Kidney Tumors
Stalter, G., Siemer, S., Becht, E., Ziegler, M., Remberger, K., & Issinger, O. G. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1904 · Cited by 161
Molecular Pathways: The Hedgehog Signaling Pathway in Cancer
McMillan, R. H., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2509 · Cited by 160
Kubo, K., Shimizu, T., Ohyama, S.-I., Murooka, H., Iwai, A., Nakamura, K., Hasegawa, K., Kobayashi, Y., Takahashi, N. K., Takahashi, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm030427r · Cited by 150
The expanding field of poly(ADP‐ribosyl)ation reactions
Hakmé, A., Wong, H., Dantzer, F., & Schreiber, V. (2008) · EMBO Reports · doi:10.1038/embor.2008.191 · Cited by 148
Phase II Study of R115777, a Farnesyl Transferase Inhibitor, in Myelodysplastic Syndrome
Kurzrock, R., Albitar, M. X., Cortes, J. E., Estey, E. H., Faderl, S. H., Garcia‐Manero, G., Thomas, D. A., Giles, F. J., Ryback, M. E., Thibault, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.082 · Cited by 148
Jiang, H., Taggart, J. E., Zhang, X., Benbrook, D. M., Lind, S. E., & Ding, W. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.032 · Cited by 147
Chen, S.-F., Ruben, R. L., & Dexter, D. L. (1986) · PubMed · Cited by 141
Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity
Abonía, R., Insuasty, D., Castillo, J., Braulio Insuasty, O., Jairo Quiroga, P., Nogueras, M., & Cobo, J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.039 · Cited by 140
Structural Basis of Selective Inhibition of Human Tankyrases
Narwal, M., Venkannagari, H., & Lehtiö, L. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201510p · Cited by 137
Characterization of novel inhibitors of histone acetyltransferases
Eliseeva, E. D., Valkov, V., Jung, M., & Jung, M. O. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0159 · Cited by 129
Sangani, C. B., Makawana, J. A., Zhang, X., Teraiya, S. B., Lin, L., & Zhu, H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.018 · Cited by 125
Chen, Y., Zhao, Y., Lu, C., Tzeng, C., & Wang, J.-P. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.02.039 · Cited by 118
Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives
Tseng, C.-H., Chen, Y., Lu, P., Yang, C.-N., & TZENG, C. ‐. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.12.028 · Cited by 117
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma
Mao, X., Li, X., Sprangers, R., Wang, X., Venugopal, A. L., Wood, T. E., Zhang, Y., Kuntz, D. A., Coe, E., Trudel, S., et al. (2008) · Leukemia · doi:10.1038/leu.2008.232 · Cited by 117
Sun, J., Zhu, H., Yang, Z., & Zhu, H. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.11.039 · Cited by 115
Emerging Bcl-2 inhibitors for the treatment of cancer
Azmi, A. S., Wang, Z. P., Philip, P. A., Mohammad, R. M., & Sarkar, F. H. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.515210 · Cited by 113
A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline
Caprio, V. E., Guyen, B., Opoku‐Boahen, Y., Mann, J., Gowan, S. M., Kèlland, L. R., Read, M. A., & Neidle, S. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00378-4 · Cited by 112
Wang, Y., Ai, J., Wang, Y., Chen, Y., Wang, L., Liu, G., Geng, M., & Zhang, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101340q · Cited by 111
Cui, J. J., McTigue, M. A., Nambu, M. D., Tran‐Dubé, M., Pairish, M., Shen, H., Jia, L., Cheng, H., Hoffman, J. E., Le, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300967g · Cited by 108
Zhou, Q. Y., Melkoumian, Z., Lucktong, A., Moniwa, M., Davie, J., & Strobl, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003106200 · Cited by 104
Antiangiogenic effects of the quinoline-3-carboxamide linomide.
Vukanovic, J., Passaniti, A., Hirata, T., Traystman, R. J., Hartley‐Asp, B., & Isaacs, J. T. (1993) · PubMed · Cited by 104
Dexter, D. L., Hesson, D. P., Ardecky, R., Rao, G. V., Tippett, D., Dusak, B. A., Paull, K. D., Plowman, J., DeLarco, B. M., & Narayanan, V. L. (1985) · PubMed · Cited by 103
Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review
Bajwa, N., Liao, C., & Nikolovska‐Coleska, Z. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.644274 · Cited by 99
Cao, Z., Harris, N., Kozielski, A. J., Vardeman, D., Stehlin, J. S., & Giovanella, B. C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9607562 · Cited by 99
Beall, H. D., Murphy, A.-M., Siegel, D. J., Hargreaves, R. H. J., Butler, J., & Ross, D. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10499-9 · Cited by 96
Chen, H., Yang, Z., Ding, C., Chu, L., Zhang, Y., Terry, K., Liu, H., Shen, Q., & Zhou, J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.023 · Cited by 94
Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles
Boschelli, D. H., Wang, Y. D., Ye, F., Wu, B., Zhang, N., Dutia, M. D., Powell, D. W., Wissner, A., Arndt, K. T., Weber, J. M., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000420z · Cited by 91
Current Status and Perspectives in the Development of Camptothecins
Zunino, F., Dallavalle, S., Laccabue, D., Beretta, G. L., Merlini, L., & Pratesi, G. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023392801 · Cited by 88
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases
Mai, A., Rotili, D., Tarantino, D., Nebbioso, A., Castellano, S., Sbardella, G., Tini, M., & Altucci, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.097 · Cited by 88
Moffat, D. F. C., Patel, S. R., Day, F. A., Belfield, A. J., Donald, A., Rowlands, M., Wibawa, J. I. D., Brotherton, D. H., Stimson, L., Clark, V., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101177s · Cited by 85
Ramachandran, E., Thomas, S. P., Poornima, P., Kalaivani, P., Prabhakaran, R., Padma, V. V., & Natarajan, K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.026 · Cited by 85
Kemnitzer, W. E., Kuemmerle, J., Jiang, S., Zhang, H., Sirisoma, N. S., Kasibhatla, S., Crogan‐Grundy, C., Tseng, B., Drewe, J. A., & Cai, S. X. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.110 · Cited by 84
Su, T.-L., Chou, T., Kim, J. Y., Huang, J., Ciszewska, G. R., Ren, W.-Y., Otter, G. M., Sirotnak, F. M., & Watanabe, K. A. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00017a006 · Cited by 83
Lord, A.-M., Mahon, M. F., Lloyd, M. D., & Threadgill, M. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8013629 · Cited by 82
Mulakayala, N., Rambabu, D., Raja, M. R., Chaitanya, M., Kumar, C. S., Kalle, A. M., Krishna, G. R., Reddy, C. M., Rao, M. V. B., & Pal, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.001 · Cited by 80
Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390)
Peters, G. J., Sharma, S. L., Laurensse, E. J., & Pinedo, H. M. (1987) · Investigational New Drugs · doi:10.1007/bf00175293 · Cited by 80
Synthesis and Antiproliferative Evaluation of Certain Indeno[1,2-c]quinoline Derivatives. Part 2
Tseng, C.-H., TZENG, C. ‐., Yang, C., Lu, P., Chen, H., Li, H., Chuang, Y.-C., Yang, C.-N., & Chen, Y. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1005447 · Cited by 80
Al‐Trawneh, S. A., Zahra, J. A., Kamal, M. R., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.098 · Cited by 78
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
Nien, C.-Y., Chen, Y.-C., Kuo, C., Hsieh, H., Chang, C.-Y., Wu, J., Wu, S., Liou, J., & Chang, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900685y · Cited by 76
Hassani, M., Cai, W., Holley, D. C., Lineswala, J. P., Maharjan, B. R., Ebrahimian, G. R., Seradj, H., Stocksdale, M. G., Mohammadi, F., Marvin, C. C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050758z · Cited by 76
Kulcsár, M. J., Molčanov, K., Kojić‐Prodić, B., Bellotto, L., Kralj, M., Zani, F., & Tušek‐Božić, L. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.03.011 · Cited by 73
Serda, M., Kalinowski, D. S., Mrozek‐Wilczkiewicz, A., Musioł, R., Szurko, A., Ratuszna, A., Pantarat, N., Kovačević, Ž., Merlot, A. M., Richardson, D. R., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.030 · Cited by 71
Wang, Y. D., Miller, K., Boschelli, D. H., Ye, F., Wu, B., Floyd, M. B., Powell, D. W., Wissner, A., Weber, J. M., & Boschelli, F. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00493-5 · Cited by 70
Okigaki, M., Komada, M., Uehara, Y., Miyazawa, K., & Kitamura, N. (1992) · Biochemistry · doi:10.1021/bi00155a007 · Cited by 69
Li, H., McMillen, W. T., Heap, C. R., McCann, D., Yan, L., Campbell, R. M., Mundla, S. R., King, C.-H. R., Dierks, E. A., Anderson, B. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701199p · Cited by 67
Fryatt, T., Pettersson, H. I., Gardipee, W. T., Bray, K. C., Green, S. J., Slawin, A. M. Z., Beall, H. D., & Moody, C. J. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.01.021 · Cited by 65
5-Benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as Selective Progesterone Receptor Modulators
Zhi, L., Tegley, C. M., Pio, B. A., Edwards, J. P., Motamedi, M., Jones, T. K., Marschke, K. B., Mais, D. E., Risek, B., & Schrader, W. T. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020477g · Cited by 65
Schiemann, K., Finsinger, D., Zenke, F. T., Amendt, C., Knöchel, T., Bruge, D., Buchstaller, H., Emde, U., Stähle, W. K., & Anzali, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.110 · Cited by 64
Szumilak, M., Szuławska‐Mroczek, A., Koprowska, K., Stasiak, M., Lewgowd, W., Stańczak, A., & Czyż, M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.032 · Cited by 64
Gomez, D. E., Armando, R. G., & Alonso, D. F. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00113 · Cited by 64
Wang, L., Świtalska, M., Mei, Z., Lu, W.-J., Takahara, Y., Feng, X., Sayed, I. E. T. E., Wietrzyk, J., & Inokuchi, T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.054 · Cited by 62
Pawar, V. G., Sos, M. L., Rode, H. B., Rabiller, M., Heynck, S., van Otterlo, W. A. L., Thomas, R. K., & Rauh, D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901877j · Cited by 61
Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin
Hautefaye, P., Cimetiere, B., Pierré, A., Léonce, S., Hickman, J. A., Laine, W., Bailly, C., & Lavielle, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00534-1 · Cited by 61
Yang, Y., Shi, L., Zhou, Y., Li, H., Zhu, Z.-W., & Zhu, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.014 · Cited by 57
Kakadiya, R., Dong, H., Kumar, A., Dodia, N. M., Zhang, X., Chou, T., Lee, T., Shah, A. K., & Su, T. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.061 · Cited by 56
Lee, H., Chang, J., Nien, C.-Y., Kuo, C., Shih, K.-H., Wu, C.-H., Chang, C.-Y., Lai, W.-Y., & Liou, J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201031f · Cited by 55
Łuniewski, W., Wietrzyk, J., Godlewska, J., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.032 · Cited by 49
Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Boldt, S., & Kölch, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384420 · Cited by 48
From Five- to Six-Membered Rings: 3,4-Diarylquinolinone as Lead for Novel p38MAP Kinase Inhibitors
Peifer, C., Kinkel, K., Abadleh, M. M., Schollmeyer, D., & Laufer, S. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061097o · Cited by 46
Reddy, P. V., Jensen, K. C., Mesecar, A. D., Fanwick, P. E., & Cushman, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201251c · Cited by 45
Abbas, R., Chalon, S., Leister, C. A., Gaaloul, M. E., & Sonnichsen, D. S. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1987-7 · Cited by 45
Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones
Rhee, H., Park, H. J., Lee, S. K., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.12.012 · Cited by 45
Behforouz, M., Cai, W., Mohammadi, F., Stocksdale, M. G., Gu, Z., Ahmadian, M., Baty, D. E., Etling, M. R., Al-Anzi, C. H., Swiftney, T. M., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.039 · Cited by 44
Chackal, S., Facompré, M., Houssin, R., Pommery, N., Goossens, J., Colson, P., Bailly, C., & Hénichart, J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0400193 · Cited by 41
Kemnitzer, W. E., Kuemmerle, J., Jiang, S., Sirisoma, N. S., Kasibhatla, S., Crogan‐Grundy, C., Tseng, B., Drewe, J. A., & Cai, S. X. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.012 · Cited by 41
Faidallah, H. M., & Rostom, S. A. F. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.006 · Cited by 39
Clioquinol Promotes Cancer Cell Toxicity through Tumor Necrosis Factor α Release from Macrophages
Du, T., Filiz, G., Caragounis, A., Crouch, P. J., & White, A. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130377 · Cited by 38
El-Agrody, A. M., Khattab, E. S. A. E. H., Fouda, A. M., & Al-Ghamdi, A. M. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9965-x · Cited by 38
Weiss, M. M., Harmange, J.-C., Polverino, A. J., Bauer, D., Berry, L., Berry, V. M., Borg, G., BREADY, J. V., Chen, D., Choquette, D. M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701098w · Cited by 37
Gunby, R. H., Ahmed, S., Sottocornola, R., Gasser, M., Redaelli, S., Mologni, L., Tartari, C. J., Belloni, V., Gambacorti-Passerini, C. B., & Scapozza, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060380k · Cited by 37
Lai, M.-J., Chang, J., Lee, H., Kuo, C., Lin, M.-H., Hsieh, H., Chang, C.-Y., Wu, J., Wu, S., Shey, K.-S., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.04.065 · Cited by 36
Sa̧czewski, F., Innocenti, A., Slawinski, J. J., Kornicka, A., Brzozowski, Z., Pomarnacka, E., Scozzafava, A., Temperini, C., & Supuran, C. T. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.01.034 · Cited by 31
Tseng, C.-H., Chen, Y., Yang, C., Cheng, C., Han, C., & Tzeng, C. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.035 · Cited by 29
The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors
Robinett, R. G., Freemerman, A. J., Skinner, M. A., Shewchuk, L. M., & Lackey, K. E. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.104 · Cited by 26
Delfourne, E., Robert Kiss, A., Corre, L. L., Dujols, F., Bastide, J., Collignon, F., Lesur, B. M., Frydman, A. M., & Darro, F. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.06.006 · Cited by 26
Lavrado, J., Reszka, A. P., Moreira, R., Neidle, S., & Paulo, A. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.110 · Cited by 26
Fujimoto, S. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1923 · Cited by 25
Cyclometalated phenylquinoline rhodium complexes as protein kinase inhibitors
Mollin, S., Blanck, S., Harms, K., & Meggers, E. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.04.035 · Cited by 25
Keyari, C. M., Kearns, A. K., Duncan, N. S., Eickholt, E. A., Abbott, G., Beall, H. D., & Diaz, P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301689x · Cited by 25
Benzo(h)quinoline derivatives as G-quadruplex binding agents
Paritala, H., & Firestine, S. M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.016 · Cited by 25
Ganesh, T., Min, J., Thepchatri, P., Du, Y., Li, L., Lewis, I., Wilson, L. J., Fu, H., Chiosis, G., Dingledine, R. J., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.047 · Cited by 24
Novel pyrrolo-quinoline derivatives as potent inhibitors for PI3-kinase related kinases
Peng, H., Kim, D., Sarkaria, J. N., Cho, Y.-S., Abraham, R. T., & Zalkow, L. H. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00260-7 · Cited by 23
Tegley, C. M., Zhi, L., Marschke, K. B., Gottardis, M. M., Yang, Q., & Jones, T. K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980366a · Cited by 22
Filak, L. K., Göschl, S., Hackl, S., Jakupec, M. A., & Arion, V. B. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.06.004 · Cited by 21
Anti-tumoral activity of imidazoquines, a new class of antimalarials derived from primaquine
Fernandes, I., Vale, N., de Freitas, V. A. P., Moreira, R., Mateus, N. F. D. C. B., & Gomes, P. A. C. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.081 · Cited by 20
Li, S., Guo, C., Sun, X., Li, Y., Zhao, H., Zhan, D., Lan, M., & Tang, Y. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.021 · Cited by 20
Discovery of Quinolinediones Exhibiting a Heat Shock Response and Angiogenesis Inhibition
Hargreaves, R. H. J., David, C. L., Whitesell, L. J., LaBarbera, D. V., Jamil, A., Chapuis, J., & Skibo, E. B. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7014099 · Cited by 20
A new quinoline derivative with cytotoxic activity from Streptomyces sp. neau50
Wang, X., Gong, D., Wang, J., Zhang, J., Liu, C., & Xiang, W. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.095 · Cited by 19
El‐Gohary, N. S. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0519-2 · Cited by 19
4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors
Berger, D. M., Dutia, M. D., Powell, D. W., Floyd, M. B., Torres, N., Mallon, R. G., Wojciechowicz, D. C., Kim, S., Feldberg, L. R., Collins, K. C., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.009 · Cited by 16
Jasiński, P., Zwolak, P., Terai, K., Borja–Cacho, D., & Dudek, A. Z. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9330-9 · Cited by 13
Park, C.-H., Chun, K., Joe, B., Choi, J.-H., Lee, H.-C., Ku, I.-W., Kim, H. Y., Koh, S.-H., Cho, G. W., Kim, S. H., et al. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9673-6 · Cited by 4
The anticancer potential of CITme, a quinoline derivative
Martins, S. C. C. (2011) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Cited by
Khandelwal, S., Tailor, Y. K., & Kumar, M. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2015.12.015 · Cited by 572
Biologically active quinoline and quinazoline alkaloids part I
Shang, X., Morris‐Natschke, S. L., Liu, Y., Guo, X., Xu, X., Goto, M., Li, J., Yang, G., & Lee, K. (2018) · Medicinal Research Reviews · doi:10.1002/med.21466 · Cited by 437
Comprehensive review on current developments of quinoline-based anticancer agents
Jain, S., Chandra, V., Kumar Jain, P., Pathak, K., Pathak, D., & Vaidya, A. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2016.10.009 · Cited by 394
Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs – a review
Ajani, O. O., Iyaye, K. T., & Ademosun, O. T. (2022) · RSC Advances · doi:10.1039/d2ra02896d · Cited by 305
Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry
Yadav, P., & Shah, K. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104639 · Cited by 286
Metadata
- Authors
- Afzal, O., Kumar, S., Haider, M. R., Ali, M. R., Kumar, R., Jaggi, M., & Bawa, S.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 97
- Pages
- 871-910
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2048008261
- Cited by
- 798
- References
- 133
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.